Amerinet GPO
Amerinet-GPO LLC is a Miami-based, South Korea-fulfilled B2B distributor of medical aesthetics injectables and research peptides, supplying verified licensed clinicians and research institutions worldwide through a multi-language ecommerce platform with cold-chain logistics and ISO 9001:2015 certification.
- Company typePrivate
- Founded1986
- HeadquartersAlbuquerque, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Amerinet GPO does
Amerinet-GPO LLC is a privately held B2B distributor headquartered in Miami, Florida, with an operational and fulfillment hub in Seoul, South Korea. The company resells and supplies medical aesthetics products—botulinum toxins, dermal fillers, lipolytics, and mesotherapy solutions—as well as high-purity research peptides (BPC-157, TB-500, GLP-1 analogues), to verified licensed healthcare professionals, certified specialists, registered clinics, and research institutions across global markets. The current entity was registered in 2020 as an evolution of a 25-year-old healthcare Group Purchasing Organization (GPO).
The underlying technology stack centers on pharmaceutical-grade cold-chain logistics: temperature-controlled storage and transport between 2°C and 8°C using validated thermal packaging that maintains stability for 72–96 hours, GDP-compliant distribution protocols, batch-level traceability with holographic security seals, and laboratory verification via HPLC and Mass Spectrometry (claimed 99%+ purity for research peptides). The proprietary Biot100, Biot150, and Biot200 bio-molecular modulator line, alongside OEM distribution of Innotox, Botulax, Beu-tox, Lipolab, Xeomin, Jeuveau, Dysport, and Bocouture, constitutes the catalog.
The business model is B2B unit sales via a multi-language ecommerce storefront with professional verification gating, tiered volume discounts (20%–40% off at 30+ units), and direct shipment from South Korean manufacturer facilities through DHL, FedEx, and UPS. Pricing is largely transparent (€49–€299 per unit in observable SKUs) with select premium SKUs (Xeomin, Dysport, Bocouture) available only on request. ISO 9001:2015 certification (Registration No. 041 24 1068) and CE/KFDA product certifications support cross-border distribution. The company is founder-led under an LLC structure with no disclosed institutional investors, funding rounds, or named enterprise customers.
Amerinet GPO firmographics
Firmographics- Name
- Amerinet GPO
- Legal name
- Amerinet-GPO LLC
- Website
- https://amerinet-gpo.com
- Company type
- Private
- Founded year
- 1986
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Amerinet-GPO LLC is a Miami-based, South Korea-fulfilled B2B distributor of medical aesthetics injectables and research peptides, supplying verified licensed clinicians and research institutions worldwide through a multi-language ecommerce platform with cold-chain logistics and ISO 9001:2015 certification.
- Ownership category
- akta.pro rank
Amerinet GPO industry classification
Industry- Product category
- Medical Aesthetics Distribution
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)
- akta.pro secondary industry
- Specialty Pharmacy & Biologics Distribution (CRAOAHAD)
Keywords
Where Amerinet GPO is headquartered
LocationHeadquarters
- HQ city
- Albuquerque
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Amerinet GPO business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel
Revenue model
- Medical Aesthetics Product Sales: Direct sale of premium medical aesthetics products including botulinum toxins, dermal fillers, lipolytics, and mesotherapy solutions to verified healthcare professionals globally through B2B ecommerce platform
- Research Compounds Distribution: Distribution of high-purity research peptides (BPC-157, TB-500, GLP-1 analogues) for laboratory and analytical applications
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Biot100 - Bio-Molecular Modulator - Single unit |
| Unit Pricing | Pay-as-you-go | Biot150 - Bio-Molecular Modulator - Single unit |
| Unit Pricing | Pay-as-you-go | Biot200 - Bio-Molecular Modulator - Single unit |
| Unit Pricing | Pay-as-you-go | Innotox 50 Units - Ready-to-Use Liquid Botulinum |
| Unit Pricing | Pay-as-you-go | Beu-tox 150 Units - Botulinum Toxin Type A |
| Unit Pricing | Pay-as-you-go | Lipolab PPC Solution - Deoxycholine Acid |
| Unit Pricing | Pay-as-you-go | Botulax 100iu - Botulinum Toxin Type A |
| Unit Pricing | Pay-as-you-go | Xeomin Merz 100iu |
| Unit Pricing | Pay-as-you-go | Jeuveau Botox 100iu |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Amerinet GPO product offering
Product offeringCore offering
Amerinet-GPO is a B2B global distributor of premium medical aesthetics and bio-scientific research compounds, supplying verified healthcare professionals with authenticated botulinum toxins, dermal fillers, lipolytics, mesotherapy solutions, and high-purity research peptides. The company sources directly from authorized South Korean and international manufacturers and ships worldwide via cold-chain logistics with batch traceability.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Aesthetics Product Line
Quantifiable outcome
- Temperature maintenance for 72-96 hours during transit
- +1 more outcomes
Companies that use Amerinet GPO
Customer profileSegments2 records
Ideal customer profiles2 records
Amerinet GPO technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Amerinet GPO partnerships and signals
Strategic signalScale indicators3 records
Recent moves7 records
Expansion highlights5 records
Amerinet GPO competitors and assessment
Company assessmentBroad incumbents
- Cardinal Health: Major US pharmaceutical and medical product distributor with extensive cold-chain capabilities. Comparable on the wholesale distribution model and GDP-quality logistics for sensitive medical products.
- McKesson: One of the largest pharmaceutical wholesalers globally, distributing branded and specialty pharmaceuticals including aesthetics-adjacent products. Comparable as a large-scale pharma distributor, though broader in scope than Amerinet's aesthetics-and-peptide focus.
- AmerisourceBergen (Cencora): Global pharmaceutical distribution and solutions company serving manufacturers, pharmacies, and providers. Comparable on specialty/biologic distribution at scale, especially for cold-chain therapeutics.
- Medline Industries: Manufacturer and distributor of medical supplies with broad product portfolio. Comparable as a healthcare supply distributor, though Medline's catalog is broader and less concentrated in aesthetics.
- Owens & Minor: Global healthcare products distribution and supply-chain company. Comparable wholesale distribution model with strong logistics infrastructure serving medical providers.
- Henry Schein: Large distributor of healthcare products to office-based practitioners including dental, medical, and aesthetics. Comparable target customer base (licensed professionals) and B2B procurement model, though broader in product mix.
Emerging players
- Alma Lasers: Provider of energy-based aesthetic devices, consumables, and training for clinics globally. Comparable customer base (aesthetic clinics) though Alma sells equipment/services rather than injectables distribution.
Regional players
- Concordance Healthcare Solutions: US-focused distributor of medical supplies and specialty pharmaceuticals to acute-care and alternate-site providers. Comparable as a specialty pharma/medical distributor, though primarily US-focused.
- DKSH Holding: Market expansion services company specializing in healthcare and consumer product distribution across Asia-Pacific. Comparable on the specialist healthcare distribution with strong Asian (especially Korean) sourcing relationships.
Others
- Merz Aesthetics (Merz Pharma): Manufacturer of aesthetic injectables including Xeomin and Belotero, referenced on Amerinet's storefront. Comparable as a counterpart in the medical aesthetics supply chain — peer relationship is upstream supplier rather than competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Amerinet GPO financial estimates
Financial estimateRevenue estimate
Valuation estimate
Amerinet GPO leadership team
Management profileNumber of profiles
Profiles1 record
Amerinet GPO funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Amerinet GPO M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Amerinet GPO
What does Amerinet GPO do?
Amerinet-GPO is a B2B global distributor of premium medical aesthetics and bio-scientific research compounds, supplying verified healthcare professionals with authenticated botulinum toxins, dermal fillers, lipolytics, mesotherapy solutions, and high-purity research peptides. The company sources directly from authorized South Korean and international manufacturers and ships worldwide via cold-chain logistics with batch traceability.
Is Amerinet GPO a public or private company?
Amerinet GPO is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Amerinet GPO founded?
Amerinet GPO was founded in 1986. It employs 11 to 50 people.
Where is Amerinet GPO based?
Amerinet GPO is headquartered in Albuquerque, United States, in the North America region.
How does Amerinet GPO make money?
Two revenue lines are on record. Medical Aesthetics Product Sales are the primary driver. The others are research Compounds Distribution.
Who are Amerinet GPO's main competitors?
Broad incumbents on record are Cardinal Health, McKesson, AmerisourceBergen (Cencora), Medline Industries, Owens & Minor and Henry Schein. Alma Lasers is listed as an emerging player. Regional players are Concordance Healthcare Solutions and DKSH Holding. Merz Aesthetics (Merz Pharma) is listed as an others.
Does Amerinet GPO have an API?
No public API is recorded for Amerinet GPO.
What industry is Amerinet GPO in?
Amerinet GPO's product category is Medical Aesthetics Distribution. Its primary akta.pro industry code is HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant), with a secondary code of CRAOAHAD, Specialty Pharmacy & Biologics Distribution. Its NAICS code is 325412 and its SIC code is 5122.